Sign in

CIK 0000822370

  • Non-accelerated filer
  • Smaller reporting company

Emmaus Life Sciences, Inc.

Sign in to watch
Ticker
EMMA
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
870419387
Phone
+1 310-214-0065
Business address
21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
Former names
MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
  1. 4 Open-market buy 10% owner bought 1,080,000 shares at $0.30 ($324,000)
  2. 4 Open-market buy Director bought 1,080,000 shares at $0.30 ($324,000)
  3. 4 Option exercise 10% owner acquired 523,305 shares (option exercise)
  4. 4 Option exercise Director acquired 523,305 shares (option exercise)
  5. 4 Option exercise 10% owner acquired 523,305 shares (option exercise)
  6. 4 Option exercise Director acquired 2,124,740 shares (option exercise)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Option exercise Director acquired 670,900 shares (option exercise)
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market buy Chief Medical Officer bought 500 shares at $0.79 ($395)
  11. 4 Open-market buy Chief Medical Officer bought 500 shares at an average $0.79 ($395)
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 4 Derivatives Options or other derivatives

Page 23 of 25 · 488 filings